Mediracer NCS in KIMES Busan 2022, at the BEXCO Exhibition Center 2, Oct 28-30
MVR Korea will participate KIMES Busan 2022, at the BEXCO Exhibition Center 2, Oct 28-30. Come and meet Mediracer nerve conduction studies. Read more
Mediracer NCS accepted in Australia
Mediracer NCS accepted in Australia by TGA, and included in the ARTG, Australian Register of Therapeutic Goods.
Mediracer is attending The Best Practice Show in Birmingham, Oct 12-13, 2022
Come and meet us at Henry Schein Medical stand C90. Read more
Mediracer will exhibit at The Royal College of Podiatry Annual Conference and -Exhibition 2022 in Liverpool 7-9 July
Welcome to meet us at Henry Schein Medical Stand 27! Read more
Mediracer is attending Birmingham Best Practice Oct 13-14, 2021
You will find us at stand E40 together with Henry Schein. Check out Mediracer NCS and the show offer of *free device* at Best Practice.
Mediracer opens rep office in US in 6/2021
Mediracer opens rep office in US. Our phone number for US customers is +1 201 270 7410 and email firstname.lastname@example.org.
Mediracer receives US FDA clearance for Mediracer NCS device
Mediracer is preparing to enter the US market after the US Food and Drug Administration (FDA) 510(k) review for premarket notification for the Mediracer® NCS device was successfully completed (SE) and clearance to market the device in the US was granted. The...
College of Podiatry Conference 2019
We are proud to assist The College of Podiatry Conference with our distributor Henry ScheinThe College of Podiatry Conference is one of the most important events of the year for podiatrists. In 2018 over 1,350 colleagues attended and profited from the latest...
Mediracer® NCS system was successfully completed (SE) FDA 510(k) review
Mediracer is preparing to enter the US market after the FDA 510(k) review for premarket notification for the Mediracer® NCS system was successfully completed (SE) for our CTS Carpal Tunnel Syndrome and DPN Diabetic Peripheral Neuropathy measurement. Section 510(k) of...
+358 45 899 2626
info (at) mediracer.com